2. Designation Additional Professor

3. Qualifications DCh, MD ( Psychiatry)

4. Email ID यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

5. Field of interest Addiction among women

6. Speciality clinics women clinic( NDDTC), ASHWIN( Community clinic for women)

7. Total number of publications till date 98

• _{8. Details of publications since 20onwards (the full citation)- these should be divided into journal  articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications) (Last 10 years)}

• _{Book chapters}

• _{Ambekar A, Mandal P, Prajapati N. Substance use in women: A global perspective. (2025)In Singh V, Kumar M, Garg B, Borasi M (Eds) A guidebook on women’s mental health: An international perspective. ( (pp. 185-201) TextRead, India ( 2025)}

• _{Mandal P. Addiction Psychiatry Society of India. Special Population. APSI News Buzz,2024; 2 (2) : 33-5 ISSN No. 2584-2730 (Online)}

• _{Mandal P, Sanahan R. Understanding the Impact of Pregnancy on Substance Use in Women. APSI News Buz, 2025;3 (2): 6-9 ISSN No. 2584-2730 (Online)}

• _{Ambekar A, Mandal P. Substance related disorders. In: Singh PK, Singh OP, Kumar V. editors. IPS Textbook of Undergraduate Psychiatry.1 st ed. New Delhi: Jaypee brothers medical publishers; p 90-109}

• _{Ambekar A, Mandal P. Substance related disorders. In: Singh PK, Singh OP, Kumar V. editors. IPS Textbook of Undergraduate Psychiatry.1 st ed. New Delhi: Jaypee brothers medical publishers; p 90-109}

• _{Mandal P, Verma K, Ambekar A.Management of Substance use disorders .In Treatment Guidelines for Perinatal Psychiatry. Indian Association of Private Psychiatry and Indian Association of Biological Psychiatry. Under Publication}

• _{Project reports/ Manuals/ SOPs}

• Training module for functionaries working in Integrated Rehabilitation Centres for Addicts (IRCAs) (under publication)

• Standard Operating Procedures for Prevention and Intervention for Substance use in school premises (2024)

• Report of the Project on Screening and Intervention for Drug/Substance Use among School going Children ( 2024)

• Dhawan A. Bhargava R, Chatterjee B, Mandal P, Malhotra S. Extent of mental health issues and addictive behaviour among adolescents seeking help in adolescent friendly health clinics in Delhi. Submitted to the Directorate of Health & Family welfare, Govt. of NCT & Delhi ( 2020)

• Dhawan A, Chatterjee B, Bhargava R, Mandal P, Rao R, Chopra A, Ambekar A, Mishra A, Agggarwal A, Chadda R, Khandelwal S on behalf of the group of investigators of the Focused Thematic Study: Student Survey (2019). Survey on Substance use among school and college students. New Delhi: Ministry of Social Justice and Empowerment, Government of India.

Journal articles

• Kaur G, Patel V, Mandal P, Agrawal A, Dayal P.Ambekar A. Long-term non-prescription use of Dexamethasone and Cyproheptadine with metabolic and endocrine sequelae. Prim Care Companion CNS Disord 2025;27(5):25cr04008

• Mandal P, Vashisht A. Psychoactive substance use and liver health: looking through a gender lens. Indian J Gastroenterology editorial ACCEPTED

• Mandal P, Rajkumar S, Yesh SC, Atul A. Buprenorphine maintenance treatment and its outcome among opioid dependent pregnant women: A case series from India. Indian J Psychiatry 2025;67(8): 809-12

• _{Jhajharia A, Saha P, Mandal P, Ambekar A. Out-patient based buprenorphine assisted opioid withdrawal management: A Preliminary prospective observational study. Indian J Psychiatry 2025;67(4): 428-431 | DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_1084_2}

• _{Mandal P, Ambekar A, Choudhary H, Bagri S. Outcome of Buprenorphine maintenance treatment among Indian females with opioid dependence: Report from a tertiary addiction treatment center. Indian J Psychiatry 2025; 67(3): 303-9| DOI: 10.4103/indianjpsychiatry_928_24}

• _{Dhawan, A., Bhargava, R., Mandal, P, Kuppili PP, Chopra, A. Opioid Use Among Treatment-Seeking Adolescents in a Tertiary Care Hospital in India: A Comparative Retrospective Study. Journal Child Adol Subst Use 2025;30(3), 132–9. https://doi.org/10.1080/29973368.2025.2491704}

• _{Verma K, Mandal P, Ambekar A, Chakma P, Roy B. Self-stigma among men and women seeking treatment for opioid dependence: a cross-sectional comparative study. Int j Sci Research 2025; 14( 6)| print ISSN No. 2277 - 8179 DOI : 10.36106/ijsr}

• _{Rathee AD, Surbala Y; Gupta S, Mandal P.Factors associated with integration of people recovering from alcohol dependence syndrome with their family: An exploratory study. Industrial Psychiatry Journal ():10.4103/ipj.ipj_344_23, May 23, 2024.}

• _{Jain R, Mandal P, Rana S. An efficient LC-QTOF-mass spectrometry method for monitoring naltrexone compliance in urine of opioid-dependent subjects. 2024, 20(1):5-9. DOI: https://doi.org/10.5055/jom.0841}

• _{Mandal P, Mittal S, Chadda RK. Polysubstance use in South Asia. Curr Opin Psychiatry. 2023 Jul 1;36(4):269-276. doi: 10.1097/YCO.0000000000000869. Epub 2023 Apr 25. PMID: 37185341}

• _{Chattopadhyay A, Sarkar S, Mandal P, Sood E, Thakur A. Common Barriers and Facilitators of Addiction Treatment among Treatment-Seeking Population. Indian Journal of Social Psychiatry 38(1):p 32-37, Jan–Mar 2022. | DOI: 10.4103/ijsp.ijsp_368_21}

• _{Sarkar S, Thakur A, Sood A, Mandal P .Barriers and Facilitators of Addiction Treatment: A Qualitative Study. International Journalof Mental Health and Addiction ISSN 1557-1874 Int J Ment Health Addiction DOI 10.1007/s11469-020-00394-x Q1}

• Sarkar S, Tom A, Mandal P. Barriers and Facilitators to Substance Use Disorder Treatment in Low-and Middle-Income Countries: A Qualitative Review Synthesis, Substance Use & Misuse, 2021,56:7, 1062-73, DOI: 10.1080/10826084.2021.1908359

• _{Vishwakarma A, Tarwani J, Chawla N, Dayal P, Agrawal A, Mandal P, Ambekar A. Mephentermine dependence with induced psychosis: a series of two cases, J Subst Use, 2020. DOI: 10.1080/14659891.2020.1749949}

• _{Chattopadhyay A,Gupta S, Dayal P,Mandal P, Agrawal A, Ambekar A. Butorphanol dependence in a health-care professional: A case report with narrative review. J Subst Use 2019; 24(5):463-4. Doi:10.1080/14659891.2019.1604839}

• _{Mandal P, Parmar A, Ambekar A, Dhawan A. Substance use among treatment seeking Indian adolescent girls: Are they unique? Asian J Psychiatr. 2019;41:17-9. doi: 10.1016/j.ajp.2019.03.007. Epub 2019 Mar 6.}

• _{Chawla N, Mandal P, Chatterjee B, Dhawan A. Tramadol associated pica: A case report. Psychiatry clinNeurosci. 2019 ;73(1):43. doi: 10.1111/pcn.12789. Epub 2018 Dec 2.}

• _{Mandal P, Dhawan A. Interventions in individuals with specific needs. Indian J Psychiatry2018,60(8): 553-58}

• _{Dhawan A, Mandal P. Preventive strategies for substance use. Indian J Soc Psychiatry2017,33(2):108-11}

• _{Ambekar A, Parmar P. Tirthani S, Mandal P. Profile of women substance users seeking treatment at tertiary care treatment centre: A retrospective chart review study. J Subst Use 2017, 22( 5): 507-10.doi.10.1080/14659891.2016.1255792}

• _{Mandal P, Parmar P. Tirthani S, Ambekar A. Profile of elderly women seeking treatment for substance use disorders at a tertiary care treatment centre. J Subst Use 2017,22(3):353-55.doi.org/10.1080/14659891.2016.1217092}

• _{Parmar A, Mandal P, Tripathi M, Sagar R Escitalopram Induced Hyponatremia. ASEAN J Psychiatry 2016, 17 (2): 254-57 Q -NA}

• _{Gupta P,  Mandal P,  Singh D,   Pattanayak RD,  Bhargava R, Anju Dhawan A. Detection of Optic Neuropathy and 3-month Follow-up of an Adolescent Inhalant User: Are we Paying Enough Attention? Indian J Psychol Med. 2016; 38(5): 486–88.doi:  10.4103/0253-7176.191390}

• _{Mandal P,Prakash S."Tramadol: a good option for management of opioid withdrawal syndrome in developing countries." J Subst Use, 2016,21(4) : 339–40}

• _{Rao R, Mandal P , Gupta R, Ramshankar P , Mishra A , Ambekar A , Jhanjee S, Dhawan A. Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India. J Subst Abuse Treat. 2016;(61):13–7}

• _{Pal A, Parmar A, Mandal P, Sagar R. A case of persistent delusional disorder: Role of dimensions of delusion reappraised. J Mental Health Human Behav. 2016; 21(1): 64-5}

• _{Mandal P, Jain R, Jhanjee S, Sreenivas V. Psychological Barriers to Tobacco Cessation in Indian Buprenorphine-Naloxone Maintained Patients: A Pilot Study. Indian J Psychol Med. 2015 Jul-Sep; 37(3): 299–304. doi:  10.4103/0253-7176.162944}

• _{Prakash S, Mandal P. Is dhat syndrome indeed a culturally determined form of depression? Ind J Psychol Med 2015; 37(1):108-9}

• _{Prakash S, Mandal P. Drug trials in psychiatry: Methodological issues. Asian J Psychiatry. 2014; 8:109-10.}

• _{Prakash S, Mandal P. Is the DSM-5 position on dhat syndrome justified?Asian J Psychiatry. 2014; 12:155-57.DOI: http://dx.doi.org/10.1016/j.ajp.2014.08.006}

• _{Prakash S, Mandal P. Psychiatry’s dilemma: A poorly valid symptom based classification versus a yet infantile neuroscience based classification. Asian J Psychiatry. 2014;13:83-4}

• _{Prakash S, Mandal P. Dhat syndrome: An extremely unusual presentation. World Cul Psych Res Rev 2014; 9 (3): 140-3}

• _{Prakash S, Mandal P.Medically Unexplained Somatic Symptoms – Diagnostic and Treatment Issues in the Indian Subcontinent. Am J Psychiatry.2014; 171(11):1158-9.}

• _{Gupta A, Mandal P, Rachna Bhargava R, Pattanayak RD, Sagar R, Dhawan A.Marked Exacerbation of ADHD After Onset of Inhalant Use: A Case Report. J Neuropsychiatry Clin Neurosci. 2014 26(4): E6-E7}

• _{Mandal P, Prakash S, Sagar R. Primary caregivers of schizophrenia outpatients: burden and its correlates. Delhi Psychiatry J. 2014; 17(2):343-8.}

• _{Prakash S, Mandal P.Is the DSM-5 position on dhat syndrome justified? Asian J psychiatry. 2014, 27(12):155-7.}

• _{Mandal P, Prakash S. Stigma of mental disorders and role of nursing professionals: A developing country perspective. J nursing & care. 2014; 3(5):190. http://dx.doi.org/10.4172/2167-1168.1000190}

• _{Mandal P, Prakash S. Methodological considerations in studying psycho-social aspects of suicide. Ind J psychiatry. 2014; 56 (2):208-9.}

• _{Prakash S, Mandal P. Improving somatic health in severe mental illness. Acta Psychiatr Scand. 2014; 129(3):236-7.}

• _{Prakash S, Mandal P. Natural Disasters, Armed Conflict, and Public Health. N Eng J Med. 2014; 370(8):783.}

• _{Srivastava P, Mandal P, Mehta M, Sagar R. Psychological Intervention in a Case of Bulimia Nervosa: A Case Report. Psychol Studies. 2014; 59(1):68–75.}

• _{Prakash S, Mandal P. Culture bound syndromes: Nosological and management issues. Ind J Psychiatry 2014; 56(1):99.}

• _{Mandal P, S. Arumuganathan, Rajesh Sagar, Pakhi Srivastava. A Classical Case of Bulimia Nervosa from India. Indian J Psychol Med .2013; 35 (3): 309-10.}

• _{Mandal P, Prakash S, Deb KS. Schizophrenia caregivers’ burden: Need to look deeper. Asian J Psychiatry. 2013 Oct; 6(5):428.}

• _{Mandal P, Pal A, Sagar R. Common mental disorders-A review. J Mental Health Human Behav 2013,8(2):6-14}

• _{Prakash S, Mandal P, Sagar R. Paroxetine in the treatment of recurrent brief depressive disorder. J Pharmacol Pharmacother. 2013; 4(4): 288–290.}

• _Thapa R, Mallick D, Mandal P, Ghosh A. Neuroblastoma masquerading as juvenile idiopathic arthritis. Indian J Pediatrics. 2007; 74(4): 421-422

• _{Abstracts in peer reviewed journal}

• _{Mandal P. Buprenorphine Assisted Opioid Withdrawal Management in the Out-Patient Setting: A Prospective Observational Study. Indian J Psychiatry 2025; 67 (Suppl 1): 60}

• _{Mandal P. Role of significant others involvement in retention and outcome on naltrexone among opioid dependent individuals: An open label pilot study. Indian J Psychiatry 2025; 67 (Suppl 1): 79-80}

• _{Choudhury H, Mandal P, Ambekar A. Clinical profile of women on agonist maintenance treatment: Data from a tertiary centre in India. Indian Journal of Psychiatry2023; 65(S- 1): S95.}

• _{Jhanjee S, Mandal P, Quraishi R, Singh YC. Symposium: Areca nut use: time to address this public health challenge. Indian Journal of Psychiatry: January 2023; 65 (S- 1): S49-50 Q3}

• _{Mandal P. Psycho-social correlates of drug use among attendees of Women’s Clinic of national level addiction treatment centre. Indian Journal of Psychiatry2023;65(S-1): S95}

• _{Mandal P, Thapa p. Measuring quality of life among recipients of opioid agonist treatment-current update. Indian J Psychiatry 2022; 64 (S-3): S-678}

• _{Dayal P, Sarkar S, Mandal P, Sharma K. Use of Tramadol Therapeutically for the Treatment of Opioid Dependence: Rationale, Experience and Caveats. Indian J Soc Psychiatry 2022; 38 ( 4): 387}

• _{Quraishi R, Mandal P, Deep R, Kathiresan P. Genetic Underpinnings of Mental and Substance Use Disorders: Current Understanding and Potential Scope. World Soc psych 2021; 3(3): 276}

• _{Verma K, Mandal P, Mongia M, Ambekar A. Perceived stigma and Affiliate stigma among family members of opioid dependent men and women: A cross sectional comparative study. Indian J Psychiatry 2020; 62(S1): S31}

• _{Jhanjee S, Mandal P, Chatterjee B. Tobacco use in vulnerable populations in India: A review. Indian J Psychiatry 2020; 62(S1): S93}

• _{Chatterjee B , Mandal P , Rao R , Kattula D. Rehabilitation of special populations in addiction psychiatry. Indian J Soc Psychiatry 2019; 35(4): 275}

• _{Verma K, Mandal P, Mongia M, Ambekar A. Perceived stigma in female opioid users and their family members: A cross sectional comparative study. Indian J Soc Psychiatry 2019; 35(4): 287}

• _{Ambekar A, Mandal P , Pakhre A , Tripathi R. Substance Use Disorders in Women – Assessment and Management Issues. Indian J Psychiatry. 2019; 61 (S- 3): 435}

• _{Parmar A, Mandal P, Ambekar A, Dhawan A. Substance use among female adolescents seeking treatment: A study from a tertiary care substance use treatment centre. Indian J Soc Psychiatry. 2018;34(4): 352}

• _{Jhanjee S, Jain R, Mandal P. E-cigarettes in adolescents: Issues and challenges. Indian J Psychiatry. 2018; 60:S-43}

• _{Mandal P, Varshney M, Das N, Dhawan A. Profile of adolescent opioid users seeking treatment at a national level addiction treatment centre. Indian J Psychiatry. 2018; 60: S-151}

• _{Mandal P, Kuppili PP, Bhargava R, Pattanayak RD, Dhawan A. Clinical profile and retention on pharmacological treatment among opioid dependent adolescents: A retrospective chart review. The Indian J Ped. 2017;SS-1:118}

• _{Sharma S, Mandal P, Mongia M, Ambekar A. Barriers to Treatment and Psychosocial Complications of Prescription Opioid Dependence in Women in Indian Context: A Case Report and Brief Review. Indian J Soc Psychiatry 2017, 33: S-14}

• _{Kamran A, Garg H, Varshney M, Agrawal A, Dayal P, Mandal P, Ambekar A. Iatrogenic Opioid Use Disorder In A Young Woman: A Case Report With Unique Clinical Characteristics. Indian J Psychiatry. 2017; 59(S2): 239}

• _{Shah B, Yadav P, Ambekar A, Mandal P. Gender Sensitive Substance Use Treatment Services: Challenges and Opportunities. Indian J Psychiatry 2016;58(S1): S41}

• _{Bhargava R, Mandal P, Gupta A, Dhawan A. Psychosocial Determinants of Drop-Out From Treatment At Child & Adolescent Clinic of National Drug Dependence Treatment Centre. Indian J Psychiatry 2016;58(S1): S-121}

• _{Jhanjee S, Jain R, Chatterjee B, Mandal P. E-Cigarettes Use: Is it an Acceptable Alternative? Indian J Soc Psychiatry 2016.32(4): 386} 

• _{Mandal P, Chatterjee B, Sagar R, Prakash S. Stigma Towards Mentally Ill Among Health Care Staffs in India and Way Forward. Indian J Soc Psychiatry 2016.32(4):413}

• _{Parmar A, Mandal P, Therthani S, Ambekar A. A Retrospective Chart Review of Female Substance Users Attending Outpatient Clinic at Tertiary Care Drug Dependence Treatment Centre in India. Indian J Soc Psychiatry 2016.32(4):455}

• _{Kuppili PP, Bhargava R, Mandal P, Mishra AK, Gupta A, Dhawan A. Correlates of treatment retention among children & adolescent substance users seeking treatmentin tertiary hospital in North India. Indian J Soc Psychiatry 2016.32(4):459}

• _{Chatterjee B, Mandal P, Sagar R, Kumar N. Attitude towards mentally ill among nursing Professionals: Evidence from a Tertiary Care General Hospital. Indian J Psychiatry 2015;57(S): 92}

• _{Krishnan V, Ambekar A, Mandal P, Rao R, Mishra AK. Outcomes on buprenorphine-naloxone at a tertiary care substance use facility: a retrospective chart review. Indian J Psychiatry 2015;57(S):102}

• _{Jhanjee S, Mandal P, Singh D. Tobacco use in opioid-dependent patients on buprenorphine-naloxone treatment. Ind J Psychiatry Jan 2014; 56 (Suppl 1): S19–S20}

• _{Mandal P, Jain R, Jhanjee S, Sreenivas V. Barriers of tobacco cessation among Indian buprenorphine-naloxone maintained patients. Alcohol alcohol. 2014; 49(suppl1): i6.doi: 10.1093/alcalc/agu052.19}

• _{Chatterjee B, Sagar R, Mandal P, Kumar N. Mental illness: Who do the professional blame? Ind J Psychiatry Jan 2013; 55(S 1): S61–S62}

• _{Abstracts in conference proceedings/ international database}

• _{Mandal P, Chatterjee B, Jhanjee S. Tobacco Use: Across the Life Span of Women. Abstract book ADDICON 2021, pp-28}

• _{Verma K, Mandal P,Ambekar A. Treatment Guidelines for Perinatal Psychiatry: Management of Alcohol Use Disorder. Abstract book ADDICON 2021, pp- 135}

• _{Verma K, Mandal P .Concept of Endophenotypes In Addiction. Abstract book ADDICON 2021, pp-85}

• _{Jain R, Mandal P,  Rana S. Monitoring naltrexone compliance in urine of opioid dependent subjects: A simple and fast LC-QTOF-Mass method for detection of  naltrexone in urine.  2021 Virtual NIDA International Forum  Poster & Virtual  College on Problems of Drug Dependence (CPDD)  Annual  Meeting, Virtual, 22 -24th June,2021}

• _{Mandal P, Dhawan A. Indian adolescent opioid users and their clinical profile and management challenges: A retrospective analysis of 5 years. In abstract database Joint NIDA (USA) & CPDD virtual meeting database 2020, June19-24, online}

• _{Mandal P. E-cigarette use: what is the raging debate? In: The proceedings of World congress of Mental Health. 2017 November 2-5;New Delhi, India.}

• _{Mandal P. Women and drug use: addressing the treatment needs. In: Abstracts of First national conference on Addiction Psychiatry; 2017 November 27-29;New Delhi, India.}

• _{Chawla N, Mandal P, Chatterjee B, Dhawan A.  Tramadol induced pica. In: Abstracts of First national conference on Addiction Psychiatry; 2017 November 27-29;New Delhi, India}

• _{Mandal P. The role of the glutamate and cannabinoid neurotransmitter systems in the nicotine dependence and their treatment implications. In abstracts of 34th Annual meeting of Indian Academy of Neurosciences; 2016 October 19-21; National Brain Research Centre, Manesar, India}

• _{Mandal P, Dhawan A, Bhargava R, Sharma S. A retrospective study of factors associated with management of adolescent substance use. In: the proceedings of the 7th Congress of the Asian Society for Child and Adolescent Psychiatry and Allied Professions (ASCAPAP) 2013 September 14-18, New Delhi, India}

• _{Mandal P, Chatterjee B, , Rakesh VR, Kumar N, Sagar R. Community Attitude towards Mentally and Their Treatment among Nursing Professionals in a Tertiary Care General Hospital. In: Abstracts of the 4th World Congress of Asian Psychiatry; 2013 August 20-23; Bangkok, Thailand}

• _{Mandal P, Jain R, Jhanjee S, Sreenivas V. Tobacco use in opioid-dependent subjects on buprenorphine-naloxone maintenance treatment. In: Abstract database of NIDA International forum 2013. June 14 -17;San Diego, USA}

9. Presentations made at scientific meetings/ conferences/ workshops_{Invited lectures:}

• _{Invited as a panelist in the panel discussion titled “ Substance Use Disorder in Women: Unique Needs, Challenges and Solutions” in IPS National Symposium Women's Mental Health.on 15th December, 2024}

• _{Mandal P. Sharing our experiences of dealing with pre-natal & post-natal mothers with opioid dependence in:Motherhood and addiction: Theoretical and clinical issues for addiction professionals. ISAM 2024 Congress, 5-8 September, 2024. Istanbul, Turkey}

• _{Invited as a resource person for faculty development programme for DU faculties on 11th March,2024 at Sahid Sukhdev College of Business Studies, Delhi.}

• _{Invited as a panelist in a National Consultation on “Expanding delivery of and access to evidence-based sexualized substance use services among Men who have Sex with Men (MSM) and Transgender persons” on November 10, 2023 in Delhi by India HIV/AIDS Alliance (Alliance India) with support from the Elton John AIDS Foundation}

• _{Symposium titled “"Addiction and Women: Is there scope to examine it with a feminist perspective?" I presented “Gender Inequities Associated with Substance Use” in ISAM Congress 2023, on 2-4th November, 2023 at Marrakech, Morocco.}

• _{The Diamond Jubilee International Conference on Mental Health was organized by Department of Psychiatry, PGIMER, Chandigarh on 14-16th September. I had presented in a symposium titled “The State of Tobacco Control in India: Key Achievements and Challenges Ahead” and my topic of presentation was “Women and tobacco use: challenges specific to women.”}

• _{Interactive session o addiction with students of undergraduate courses at Shaheed Sukhdev College of Business Studies, University of Delhi, Rohini, Delhi on September 25, 2023}

• _{Invited lecture titled “Basics of substance use” for Out Reach drop In Centre (ODIC) staffs organized by National Institute of Social Defense on 21.09.2023}

• _{Invited lecture titled “Extent of substance use in India” for Outreach drop In Centre (ODIC) staffs organized by National Institute of Social Defense21.09.2023}

• _{Interactive session on addiction with students of undergraduate courses at Shaheed Sukhdev College of Business Studies, University of Delhi, Rohini, Delhi on June 12, 2023}

• _{Invited in the expert working group meeting of the 2023 UNODC Expert working group op opiate trafficking along the southern route” held on 10-11th May, 2023 in Delhi}

• _{Delivered symposium titled“Women Substance use in Modern times- Liberating or Enslaving?” In WPA regional Congress on 14-16 April,2023 in Kolkata, India}

• _{Invited lecture titled “Women who use psychoactive substances: An underrecognized and underserved population” in the National Midterm CME themed “Gender and Diversity in Addiction Psychiatry”, organized by ‘Addiction Psychiatry Society of India (APSI) on 5-6 April 2023 in Imphal, India}

• _{Invited lecture titled “Magnitude of substance use among women” in the 1st Annual National Conference of Society for Addiction Psychology on 10-11 March,2023 in Ghaziabad, India}

• _{Delivered symposium titled “Caveats of using tramadol in patients with opioid dependence” in the 29th National Conference of Indian Association of Social Psychiatry 2022 held on18-20 November, 2022 in Agra, India.}

• _{Invited lecture titled “Drug Dependency among women across ages: From children to elderly” in a webinar on ‘Substance Use and Women’ organized by MoSJE as a part of ‘Naya Bharat, Nasha Mukt Bharat’ programme under ‘Nasha Mukt Bharat Abhiyan’ on June 8th, 2022.}

• _{Invited lecture titled “Basic Understanding of Substance Use” for transgender community members at National Institute of Social Defence on June 10, 2022 in Delhi}

• _{Invited lecture titled “Risk and Protective factors – Adverse Childhood Experiences” for transgender community members at National Institute of Social Defence on June 10, 2022 in Delhi}

• _{Delivered symposium titled “Tobacco use: Across life span of women” in ADDICON 2021, Virtual, 10-11th December,2021, India}

• _{Delivered symposium titled “School setting and intervention: Background and review”. Presented at WASP Asia-Pacific Hybrid congress, 16-18th September,2021, New Delhi, India}

• _{Delivered symposium titled “Genes and gender differences in substance use”. Presented at Hybrid WASP Asia-Pacific Hybrid congress, 16-18th September,2021, New Delhi, India}

• _{Delivered symposium titled “Interventions for substance use in school setting”. Presented at Hybrid NCIASP , 26-28th November, 2021, Imphal, Manipur, India}

• _{Delivered invited lecture titled “Management of Opioid Dependence -withdrawal management” online for Online Orientation Programme for Resource persons (Psychiatrists) on Management of SUD organized by NDDTC funded by The Drug De-Addiction Programme, Ministry of Health and Family Welfareon 1-6th March, 2021}

• _{Delivered invited lecture titled “Management of Opioid Dependence -withdrawal management” online for Online Orientation Programme for Resource persons (Psychiatrists) on Management of SUD organized by NDDTC funded by The Drug De-Addiction Programme, Ministry of Health and Family Welfareon 19-24th October, 2020}

• _{Delivered symposium titled “Women and tobacco use” in 72nd Annual National Conference of Indian Psychiatric Society held on January 22-25,2020 Kolkata}

• _{Delivered symposium titled “Rehabilitation in women” in National Conference of the Indian Association for Social Psychiatry (NCIASP) held on 29 November – 01 December, 2019Bhubaneswar}

• _{Delivered invited lecture titled “ Opioid Dependence Syndrome” in the Nurses training of trainers program on substance use disorders, AIIMS Delhi College of Nursing on 30th November,2019}

• _{Delivered symposium titled “Addressing the need: More women psychiatrists to fill the gap” in XXI International Society of Addiction Medicine Meeting November 13-16,2019 New Delhi}

• _{Delivered symposium titled “Intervention for substance use among adolescents across settings: scope and relevance: Interventions in the community” XXI International Society of Addiction Medicine Meeting November 13-16,2019 New Delhi}

• _{Delivered invited lecture titled “Overview of substance use disorders and relevance to the police force” for battalion 49B, PAC on 12 April, 2019 at Gautam Buddh Nagar , UP}

• _{Delivered symposium titled “ Substance Use Disorders in Women – Assessment and Management Issues ” in 71st Annual National Conference of Indian Psychiatric Society held on January 31-3rd February, 2019,Lucknow}

• _{Delivered invited lecture titled “Women in addiction; issues, concerns and service gaps” in the 7th National FINGODAP conference organized by SPYM and National Institute of Social Defence on 30thMarch, 2019 at Dr Ambedkar International Centre, New Delhi}

• _{Invited as an expert in the Regional workshop on piloting UNODC Family Treatment Package for youths with drug use disorder” (UNFT) to finalize the cultural adaptations needed in the treatment package (December 2018)in Colombo, Srilanka}

• _{Delivered symposium titled “Women & drug use: Addressing the treatment needs” in the 1st National conference on Addiction Psychiatry; organized by Dept. of Psychiatry, AIIMS, 27-29 November,2017 New Delhi, India}

• _{Delivered invited lecture titled “ Gender sensitive interventions: An overview” in the National CME on “Emerging Issues in Substance Use Disorders", New Delhi, 22nd July 2017}

• _{Delivered symposium titled “Do e-cigarettes help to quit tobacco use- what is the evidence? In symposium entitled “E- Cigarettes Use: Is it an acceptable alternative?” 22nd World Congress of Social Psychiatry (WASP). 30th November,2016, New Delhi , India}

• _{Delivered symposium titled “The role of the glutamate and cannabinoid neurotransmitter systems in nicotine dependence and their treatment implications”. 34th Annual Meeting of Indian Academy of Neurosciences. 19th October, 2016. National Brain Research Centre, Manesar, India}

Conference presentations

• _{Negi D; Mandal P; Sarkar S; Quraishi R; Ray A. Metabolic indices in Indian opioid-dependent subjects on Buprenorphine-naloxone Maintenance treatment: longitudinal study. Presented at "Annual ISAM Global Congress 2025,26-28 May, 2025. Hamburg, Germany}

• _{Dinesh M, Mandal P, Ambekar A. Treatment retention and associated factors among women with Drug dependence: A longitudinal study", at "Annual ISAM Global Congress 2025, Hamburg, Germany}

• _{Mandal P. Ambekar A. Women clinic exclusively for women with substance use problems .} 10th world congress of women's mental health 5-8 march 2025, Bengaluru, India

• _{Mandal P, Jhajharia A, Ambekar A. Buprenorphine assisted opioid withdrawal management in the out-patient setting: a prospective observational study. ANCIPS 2025 in Hyderabad, 22-25 January, 2025}

• _{Mandal P. Role of significant others involvement in retention and outcome on naltrexone among opioid dependent individuals: An open label pilot study. ANCIPS 2025 in Hyderabad, 22-25 January, 2025}

• _{Kaur G, Kaur V,Mandal P, Agrawal A, Dayal P, Ambekar A. Knocking out with a muscle relaxant: Succinylcholine misuse in a young female health-worker with multiple substance use and complex PTSD. ISAM 2024 Congress, 5-8 September, 2024. Istanbul, Turkey}

• _{Substance use among college students in India: necessity for iintervention. Dhawan A, Bhargava R, Chatterjee B, Chopra A, Mandal P, Rao R, Ambekar A, Aggrawal A. Lisbon Addictions on 23-25th October 2024 at Lisbon, Portugal}

• _{KaurG, PatelV, AmbekarA, DayalP, AgrawalA , Mandal P. Steroid and Cyproheptadine Use: A Case Report of Chronic non-prescription use and Its Metabolic Fallout. 4th Annual National Conference of Addiction Psychiatry Society of India.17-19 October, 2024. Srinagar}

• _{Sanahan R, Mandal P, Agarwal A, Dayal P, Ambekar A. Opioid prescription abuse in a patient with persistent somatoform pain disorder: A Case Report. 4th Annual National Conference of Addiction Psychiatry Society of India. 2024 Srinagar}

10. Funded projects 

• _{Principal Investigator/Co-PI in funded projects title along with year completed/ongoing}

• _{“Metabolic and addiction indices in Indian opioid dependent subjects on Buprenorphine-naloxone Maintenance treatment: A longitudinal study” under ICMR funding ( 2023-2026)}

• _{“Role of significant others involvement in retention and outcome on naltrexone among opioid dependent individuals: An open label comparative study” under AIIMS Intramural funding ( 2021-2024)}

• _{“Psycho-social correlates of drug use among attendees of Women’s Clinic of National Drug Dependence treatment Centre” under AIIMS Intramural funding ( 2017-2020)}

• _{Co-investigator in funded projects title along with year completed/ongoing}

• _{A study to examine psychosocial and behavioural domains among school going adolescents during Covid-19 pandemic: Mixed study design (ongoing)}

• _{Screening and intervention for substance use among middle school going children in Delhi funded by Dept. of Education, Samagra Siksha Abhiyan Government of Delhi & NCT ( completed)}

• _{Screening and intervention for substance use among high school going children in Delhi funded by Dept. of Education, Samagra Siksha Abhiyan , Government of Delhi & NCTA cross sectional study to measure (completed)}

• _{Extent of mental health issues and addictive behaviour among adolescents seeking help in Adolescent Friendly Health Clinics in Delhi” funded by Government of Delhi & NCT (completed)}

• _{Impact of COVID-19 pandemic and related lockdown on pattern of psychoactive substance use, treatment service utilization, psychosocial functioning, and health promoting behavior in treatment seeking alcohol and drug dependent individuals under AIIMS Covid related projects funding (completed)}

• _{Survey on alcohol and drug use among school and college students” funded by Ministry of Social Justice and Empowerment & NDDTC (completed)}

• _{Barriers and facilitators of addiction treatment: A qualitative study funded by ICSSR (completed)}

• _{Development and pilot-testing of training modules on Substance Use for staff working in Integrated Rehabilitation Centre for Addicts (IRCAs) and Child Welfare Police Officers (CWPOs)funded byMoSJE, GOI (ongoing)}

11. Non funded projects  

1. _{Principal Investigator/Co-PI in non-funded projects title along with year completed and ongoing}

• _{Metabolic and addiction indices in Indian females with opioid dependence: A cross-sectional study (ongoing)}

• _{Experiential account of substance use and treatment seeking among women Treatment Attendees of a Tertiary Addiction Treatment Centre: A Qualitative Study(ongoing)}

• _{Opioid dependence and its management during pregnancy and postnatal period: A retrospective chart review (Completed)}

• _{Outcome of buprenorphine-naloxone maintenance treatment for opioid dependence among women: A retrospective chart review (Completed)}

 B. Co- investigator in non-funded projects title along with year completed and ongoing

• _{Detection of naltrexone in urine by LC-QTOF-Mass spectrometry and its application to naltrexone compliance in substance users (Completed)}

• _{An efficient screening method for simultaneous detection of Pentazocine, Pheniramine and Tramadol in urine of substance users by gas chromatography-Mass spectrometry (Completed)}

• _{COVID-19 experience and literacy among substance use disorder (SUD) patients.(Completed)}

12. Thesis supervised for MD/ PhD
- As guide (number only) 3- As co-guide (number only)5

13. Significant events/achievements/awards

14. Other relevant informationMembership of professional bodies

• _{Life Fellow of Addiction Psychiatry Society of India}

• _{Life fellow of the Indian psychiatric Society}

• _{Life fellow of the Indian Association for Social psychiatry}

• _{Life membership of the Society for Promotion of Research & Education in Mental Health & Substance Use (SPREMH)}

• _{Selected member of Autism Certification Board of department of Psychiatry & NDDTC, AIIMS}

Peer reviewer for

• _{Journal of Psychosocial Rehabilitation and Mental Health}

• _{Frontiers in Psychiatry}

• _{Transcultural Psychiatry}

• _{Journal of Psychoactive Drugs ( International)}

• _{International Journal of Psychiatry in Medicine ( International)}

• _{Journal of Substance Use (International)}

• _{Indian Journal of Social Psychiatry}

• _{Journal of Mental Health and Human Behaviour}

• _{National Medical Journal}